This site is intended for health professionals only

Home / News / Serious shortage protocols issued for Fluoxetine and Salazopyrin

Serious shortage protocols issued for Fluoxetine and Salazopyrin

By Isabel Shaw

22 Oct 2020

Two new serious shortage protocols (SSPs) for Fluoxetine 30mg capsules and Salazopyrin EN-Tabs 500mg have been issued by the Department of Health and Social Care (DHSC) to combat shortages.

The SSPs, which apply to all pharmacies in England, Wales and Northern Ireland, were introduced with immediate effect on Tuesday (20 October) and are due to expire on 4 December (Salazopyrin) and 22 December (Fluoxetine).

The protocols were put in place in response to ‘significant ongoing disruption’ to the supply of both drugs, PSNC said.

Both SSPs provide pharmacists with procedures to follow for supplying a suitable alternative product to patients.

Fluoxetine 30mg capsules were subject to a SSP in October last year, along with two other strengths of the antidepressant.

Earlier this month (5 October), the SSP for Fluoxetine 40mg capsules was withdrawn after ‘sufficient stock’ of the drug had been made available to meet ‘normal demand’.

A full list of active SSPs have been published on the NHS Business Services Authority’s website.

Want news like this straight to your inbox?

Latest News

Regulator was wrong in finding pharmacist’s words were ‘not antisemitic’, High Court says
The High Court has upheld an appeal against a GPhC ruling that comments made by...
PDA condemns satirical ‘attack’ on pharmacist MP
A national newspaper and satirical website have been accused of ‘attacking’ pharmacist and MP for...
booster jab
Pharmacies should lead on Covid booster jabs to free up GPs’ time
Community pharmacies should play a 'significant role' in the Covid booster vaccine delivery plan, pharmacy...